FDA Drug recall D-1287-2014
Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringe, 22.5 mg for 3-mo…
- FDA Drug
- Class II
- terminated
- Published 2014-05-07
On 2014-05-07 the FDA classified a Class II recall of Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringe, 22.5 mg for 3-mo… by Abbvie, citing defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1287-2014 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2014-03-10 |
| Published | 2014-05-07 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Abbvie |
| Distribution | US |
Product
Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringe, 22.5 mg for 3-month administration, Rx only, Manufactured for: AbbVie Inc., North Chicago, IL 60064; by: Takeda Pharmaceutical Company Limited, Osaka, Japan 540-8645; NDC 0074-3346-03, UPC 3 00743 34603 9.
Reason
Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
Identifiers
| upc | 300743346039 |
|---|---|
| ndc | 0074-3473-03 |
| ndc | 0074-3473-55 |
| ndc | 0074-9945-01 |
| ndc | 0074-0009-01 |
| ndc | 0074-3683-03 |
| ndc | 0074-3683-55 |
| ndc | 0074-9930-01 |
| ndc | 0074-3642-03 |
| ndc | 0074-3642-55 |
| ndc | 0074-9907-01 |
| ndc | 0074-3346-03 |
| ndc | 0074-3346-55 |
| ndc | 0074-9922-01 |
| code_info | Lot #: 1014204, Exp 10/11/15; 1014485, Exp 12/11/16; and 1015007, Exp 12/06/16 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Other recalls by Abbvie
- PRED MILD, prednisolone acetate ophthalmic suspension, USP, 0.12%, 10 mL, Sterile, Rx only, Allergen, Inc., an AbbVie company, North Chicag…
FDA Drug · Class III · 2026-06-03 · Abbvie - Refresh LACRI-LUBE, (42.5% Mineral Oil, 57.3% White Petrolatum) Lubricant Eye Ointment, Net wt, 0.12 oz (3.5g) Tube, Distributed by: Allerg…
FDA Drug · Class II · 2024-10-02 · Abbvie - Refresh P.M., (Mineral Oil 42.5%, White Petrolatum 57.3%) Lubricant Eye Ointment, Net wt, 0.12 oz (3.5g) Tube, Distributed by: Allergen, an…
FDA Drug · Class II · 2024-10-02 · Abbvie - Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, Rx Only AbbVie Inc
FDA Drug · Class III · 2023-11-15 · Abbvie - Ultane (sevoflurane), 250 mL, Inhalation Anesthetic, Rx only, Manufactured by: AbbVie Inc., North Chicago, IL 60064, USA. NDC 0074-4456-51
FDA Drug · Class III · 2018-02-07 · Abbvie
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1287-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.